An interventional study of Self-efficacy App in Stress and Self Efficacy, sponsored by University of Zurich. Completed at 1 site in Switzerland. Open to participants aged 18 Years to 29 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-11-15.
Sponsored by University of Zurich · Not applicable, Interventional, and Prevention
The study investigates the effects of a digital, scalable self-efficacy training of repeated recall of self-efficacy memories on mental health outcomes, such as self-efficacy, anxiety, stress, hopelessness, and other mental health outcomes. A total of 94 students with elevated stress levels (≤ 13 on the Perceived Stress Scale) will be recruited and randomly assigned to training and control group. Individuals will either engage in the self-efficacy training app combined with Ecological Momentary Assessment (EMA) for 1 week (training group) or in EMA only for 1 week (control group). Baseline and post assessments will measure changes in self-efficacy, anxiety, stress, hopelessness, and other mental health outcomes.
Self-efficacy is associated with positive mental health outcomes and has been proposed as a putative contributor to therapeutic outcomes in the treatment of mental health problems. It can be enhanced through experimental inductions and the recall of autobiographical mastery experiences, which have mostly been conducted in person and in the laboratory until today.
The study will investigate effects of a digital, scalable self-efficacy training of repeated recall of self-efficacy memories on mental health outcomes, such as self-efficacy, anxiety, stress, hopelessness, and other mental health outcomes. The study will recruit 94 students with elevated stress levels (≤ 13 on the Perceived Stress Scale) and randomly assigned them to training and control group. Individuals will either engage in the self-efficacy training app combined with Ecological Momentary Assessment (EMA) for 1 week (training group) or in EMA only for 1 week (control group). Baseline and post assessments will measure changes in self-efficacy, anxiety, stress, hopelessness, and other mental health outcomes.
University of Zurich is the lead sponsor of 1,030 studies on the registry; 130 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
-current psychiatric disorder
This group will receive a digital one week self-efficacy training with three training sessions per day and EMA (10 per day).
Behavioral: Self-efficacy App
This group will receive EMA questionnaires for one week (10 per day).
The training starts with a psychoeducational video and instructions to define two autobiographical self-efficacy The individuals will then receive three self-efficacy trainings per day based on their autobiographical memories and combined with a slow breathing exercise. Additionally, they will receive 10 daily EMA questionnaires on mood, social contacts, and virtual context.
General self-efficacy
The General Self-Efficacy Scale (Schwarzer \& Jerusalem, 1995; Tipton \& Worthington, 1984) will measure the general self-efficacy.
Time frame: change from baseline to 1 day post intervention; time frame: 1 week
Perceived stress
The Perceived Stress Scale (Cohen, Kamarck, \& Mermelstein, 1983; Klein et al., 2016) will measure perceived stress.
Time frame: change from screening to 1 day post intervention; time frame: 1 week
Positive and negative affect
change from baseline to 1 day post intervention; time frame: 1 week
Time frame: The Positive and Negative Affect Scale (Krohne, Egloff, Kohlmann, & Tausch, 1996; Watson, Clark, & Tellegen, 1988) will measure positive and negative affect.
Hope
The Trait Hope Scale (Krause, 2002; Snyder et al., 1991) will measure hope.
Time frame: change from baseline to 1 day post intervention; time frame: 1 week
Depression
change from baseline to 1 day post intervention; time frame: 1 week
Time frame: The Beck Depression Inventory-II (Beck, Steer, Ball, & Ranieri, 1996; Kuhner, Burger, Keller, & Hautzinger, 2007) will measure depression.
Anxiety
State-Trait Anxiety Inventory (Laux, Glanzmann, Schaffner, \& Spielberger, 1981; Spielberger, Gorsuch, Lushene, Gagg, \& Jacobs, 1983) will measure state and trait anxiety.
Time frame: change from baseline to 1 day post intervention; time frame: 1 week
Hopelessness
The Beck Hopelessness Scale (Beck, Weissman, Lester, \& Trexler, 1974; Kliem, Lohmann, Mossle, \& Brahler, 2018) will measure hopelessness.
Time frame: change from baseline to 1 day post intervention; time frame: 1 week
Positive and negative affect
EMA will capture positive and negative mood at 10 time points per day during the one week study participation. We will measure positive mood using three items (cheerful, happy, and relaxed) and negative mood using seven items (irritated, anxious, insecure, lonely, sad, overthinking, and stressed).
Time frame: Daily measured; changes in the course of the study participation
Dissatisfaction with social contacts
EMA will capture dissatisfaction with social contacts at 10 time points per day during the one week study participation. There will be two options indicating dissatisfaction with social contacts: (a) being with nobody and feeling excluded or wanting to be with someone or (b) being with someone and rather wanting to be alone. We combined these into one variable.
Time frame: daily measured; changes in the course of the study participation
Specific self-efficacy
Specific self-efficacy will be captured once per day. Questions will focus on e. g. the participant's level of agreement with statements such as "Right now, I think I will be able to do what is necessary to make this training successful".
Time frame: daily measured in training group only; changes in the course of the study participation
Virtual context
EMA will capture virtual context at 10 time points per day during the one week study participation. Questions will be about who the person is with and how they feel about it.
Time frame: daily measured; changes in the course of the study participation
Plan to share: Undecided — It is planned to make the anonymised data available on a public repository.
No publications or documents are linked to this record.
This study is completed, as verified in Nov 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Zurich